Movement helps your mood, but it's not one-size-fits-all. Exercising for fun, with friends, or in enjoyable settings brings greater mental health benefits than simply moving for chores or obligations. Researchers emphasize that context — who you're with, why you're exercising, and even the weather — can make or break the mood-boosting effects. [więcej]
Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with menopause hormone therapy. A Mayo Clinic study revealed that this dual treatment led to significantly greater weight loss than tirzepatide alone. Women using both treatments lost 17% of their body weight on average, compared to 14% in [więcej]
In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant weight loss in obese mice but also slashed breast cancer tumor growth. The research, presented at ENDO 2025, links body fat reduction to better cancer outcomes, suggesting that these next-generation weight-loss drugs might offer unexpected benefits beyond [więcej]
A new UCL study reveals that aligning workouts with personality boosts fitness and slashes stress—extroverts thrive on HIIT, neurotics favor short, private bursts, and everyone benefits when enjoyment leads the way. [więcej]
Illinois engineers fused ultrafast imaging with smart algorithms to peek at living brain chemistry, turning routine MRIs into metabolic microscopes. The system distinguishes healthy regions, grades tumors, and forecasts MS flare-ups long before structural MRI can. Precision-medicine neurology just moved closer to reality. [więcej]
Opinie różne
It's profitable to treat and "mask" the symptoms and "manage" chronic preventable disease but not profitable to address the root cause of obesity and metabolic syndrome and prevent it in the first place.
